πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 173 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9358285

Granulysin in immunotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9290541

TCL1 peptides for immunotherapy

The Board of Regents of the University of Texas System Β· Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9102752

Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type

United Biomedical, Inc. Β· Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8911722

Modulation of yeast-based immunotherapy products and responses

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883500

Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherap

Northwestern University Β· Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8815229

Granulysin in immunotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8734778

Yeast-based vaccines as immunotherapy

The Regents of the University of Colorado Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8709417

Combination immunotherapy for the treatment of cancer

BOARD OF REGENTS Β· Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8597946

Enhanced dendritic cells for cancer immunotherapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8546371

Nanoparticle formulated glycolipid antigens for immunotherapy

The Board of Regents of the University of Texas System Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8337830

Yeast-based vaccines as immunotherapy

The Regents of the University of Colorado Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8338173

Preparation of antigen-presenting human Ξ³Ξ΄ T cells and use in immunotherapy

University College Cardiff Consultants Limited Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8287857

Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative l

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153426

Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy

University College Cardiff Consultants Limited Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153136

Yeast-based vaccines as immunotherapy

The Regents of the University of Colorado Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034334

Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998736

Adoptive immunotherapy with enhanced T lymphocyte survival

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919079

Cancer immunotherapy compositions and methods of use

The Regents of the University of California Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7713526

Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell car

The Regents of the University of California Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7682607

Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell car

The Regents of the University of California Β· Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7449557

Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy

University of Connecticut Health Center Β· Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7264820

Cancer immunotherapy using autologous tumor cells combined with cells expressing a membran

The Regents of the University of California Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6565827

Radioimmunotherapy of lymphoma using anti-CD20 antibodies

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6287537

Radioimmunotherapy of lymphoma using anti-CD20 antibodies

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired